Antibiotic linked to 94% higher risk of death in adults: Study
Key Points:
- A new study analyzing data from 110 clinical trials involving over 22,600 patients found that the antibiotic cefepime is associated with a 94% higher risk of death in adults compared to other antibiotics.
- Cefepime is widely used in hospitals to treat serious infections such as pneumonia, urinary tract infections, skin infections, and meningitis, particularly in immunocompromised patients.
- Concerns about cefepime's safety date back to a 2007 study, though a subsequent FDA review with additional unpublished data did not confirm a clear risk.
- The exact reasons why cefepime may carry a higher risk remain unclear, and the study does not advise against its use but suggests that healthcare providers weigh these findings when choosing antibiotics.